PTC Therapeutics
PTCT
PTCT
179 hedge funds and large institutions have $2.84B invested in PTC Therapeutics in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 56 increasing their positions, 74 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
-3
Holders Change %
-1.65%
% of All Funds
3.03%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
22
Increased
56
Reduced
74
Closed
21
Calls
$9.26M
Puts
$8.38M
Net Calls
+$881K
Net Calls Change
+$166K
Top Buyers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
$98.1M |
| 2 |
State Street
Boston,
Massachusetts
|
$145M |
| 3 |
Goldman Sachs
New York
|
$19.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$288M |
| 5 |
Invesco
Atlanta,
Georgia
|
$9.5M |
